Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

John H Stone, M.D.

Co-Author

This page shows the publications co-authored by John Stone and Zachary Wallace.
Connection Strength

17.771
  1. Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide? Front Immunol. 2019; 10:2855.
    View in: PubMed
    Score: 0.870
  2. Reply. Arthritis Rheumatol. 2020 01; 72(1):201-202.
    View in: PubMed
    Score: 0.867
  3. Disease Activity, Antineutrophil Cytoplasmic Antibody Type, and Lipid Levels in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol. 2019 11; 71(11):1879-1887.
    View in: PubMed
    Score: 0.857
  4. Immunoglobulin G4-related Disease. Clin Chest Med. 2019 09; 40(3):583-597.
    View in: PubMed
    Score: 0.855
  5. Risk of severe infection following rituximab and the efficacy of antimicrobial prophylaxis. Ann Rheum Dis. 2020 04; 79(4):e40.
    View in: PubMed
    Score: 0.821
  6. An International Multispecialty Validation Study of the IgG4-Related Disease Responder Index. Arthritis Care Res (Hoboken). 2018 11; 70(11):1671-1678.
    View in: PubMed
    Score: 0.807
  7. Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Care Res (Hoboken). 2017 07; 69(7):1004-1010.
    View in: PubMed
    Score: 0.735
  8. Association of IgG4-Related Disease With History of Malignancy. Arthritis Rheumatol. 2016 09; 68(9):2283-9.
    View in: PubMed
    Score: 0.694
  9. Predictors of disease relapse in IgG4-related disease following rituximab. Rheumatology (Oxford). 2016 Jun; 55(6):1000-8.
    View in: PubMed
    Score: 0.669
  10. IgG4-Related Disease: Clinical and Laboratory Features in One Hundred Twenty-Five Patients. Arthritis Rheumatol. 2015 Sep; 67(9):2466-75.
    View in: PubMed
    Score: 0.648
  11. An update on IgG4-related disease. Curr Opin Rheumatol. 2015 Jan; 27(1):83-90.
    View in: PubMed
    Score: 0.619
  12. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015 Jan; 74(1):190-5.
    View in: PubMed
    Score: 0.591
  13. Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review. Semin Arthritis Rheum. 2014 Jun; 43(6):806-17.
    View in: PubMed
    Score: 0.572
  14. IgG4-related disease and hypertrophic pachymeningitis. Medicine (Baltimore). 2013 Jul; 92(4):206-216.
    View in: PubMed
    Score: 0.557
  15. Dr. Wallace and Dr. Stone reply. J Rheumatol. 2013 Jul; 40(7):1232.
    View in: PubMed
    Score: 0.557
  16. Refractory relapsing polychondritis treated with serial success with interleukin 6 receptor blockade. J Rheumatol. 2013 Jan; 40(1):100-1.
    View in: PubMed
    Score: 0.539
  17. IgG4-related systemic disease as a cause of "idiopathic" orbital inflammation, including orbital myositis, and trigeminal nerve involvement. Surv Ophthalmol. 2012 Jan-Feb; 57(1):26-33.
    View in: PubMed
    Score: 0.496
  18. The association of smoking with immunoglobulin G4-related disease: a case-control study. Rheumatology (Oxford). 2021 Nov 03; 60(11):5310-5317.
    View in: PubMed
    Score: 0.248
  19. Validation of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis as the Cause of End-Stage Renal Disease in the US Renal Data System. ACR Open Rheumatol. 2021 Oct 12.
    View in: PubMed
    Score: 0.247
  20. Association of renal transplantation with reduced risk of myocardial infarction and ischemic stroke in ANCA-associated vasculitis: An observational cohort study. Semin Arthritis Rheum. 2021 Sep 26; 51(6):1180-1185.
    View in: PubMed
    Score: 0.247
  21. Perceived Risk and Associated Shielding Behaviors in Patients With Rheumatoid Arthritis During the Coronavirus 2019 Pandemic. ACR Open Rheumatol. 2021 Sep 08.
    View in: PubMed
    Score: 0.246
  22. ANCA-associated Vasculitis Management in the United States: Data From the Rheumatology Informatics System for Effectiveness (RISE) Registry. J Rheumatol. 2021 07; 48(7):1060-1064.
    View in: PubMed
    Score: 0.236
  23. Topic modeling to characterize the natural history of ANCA-Associated vasculitis from clinical notes: A proof of concept study. Semin Arthritis Rheum. 2021 02; 51(1):150-157.
    View in: PubMed
    Score: 0.234
  24. Lifetime Allergy Symptoms in IgG4-Related Disease: A Case-Control Study. Arthritis Care Res (Hoboken). 2020 Dec 20.
    View in: PubMed
    Score: 0.234
  25. Treatment Delays Associated With Prior Authorization for Infusible Medications: A Cohort Study. Arthritis Care Res (Hoboken). 2020 11; 72(11):1543-1549.
    View in: PubMed
    Score: 0.232
  26. All-cause and cause-specific mortality in ANCA-associated vasculitis: overall and according to ANCA type. Rheumatology (Oxford). 2020 09 01; 59(9):2308-2315.
    View in: PubMed
    Score: 0.229
  27. Association of Cigarette Smoking With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. JAMA Intern Med. 2020 06 01; 180(6):870-876.
    View in: PubMed
    Score: 0.225
  28. Increasing Operational Capacity and Reducing Costs of Rituximab Administration: A Costing Analysis. ACR Open Rheumatol. 2020 May; 2(5):261-268.
    View in: PubMed
    Score: 0.223
  29. Immunoglobulin G and immunoglobulin G subclass concentrations differ according to sex and race. Ann Allergy Asthma Immunol. 2020 08; 125(2):190-195.e2.
    View in: PubMed
    Score: 0.222
  30. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis. 2020 01; 79(1):77-87.
    View in: PubMed
    Score: 0.217
  31. The 2019 American College of Rheumatology/European League Against Rheumatism Classification Criteria for IgG4-Related Disease. Arthritis Rheumatol. 2020 01; 72(1):7-19.
    View in: PubMed
    Score: 0.217
  32. Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts. Ann Rheum Dis. 2019 03; 78(3):406-412.
    View in: PubMed
    Score: 0.204
  33. Rituximab for idiopathic and IgG4-related retroperitoneal fibrosis. Medicine (Baltimore). 2018 Oct; 97(42):e12631.
    View in: PubMed
    Score: 0.201
  34. Improving Mortality in End-Stage Renal Disease Due to Granulomatosis With Polyangiitis (Wegener's) From 1995 to 2014: Data From the United States Renal Data System. Arthritis Care Res (Hoboken). 2018 10; 70(10):1495-1500.
    View in: PubMed
    Score: 0.199
  35. Improved survival with renal transplantation for end-stage renal disease due to granulomatosis with polyangiitis: data from the United States Renal Data System. Ann Rheum Dis. 2018 09; 77(9):1333-1338.
    View in: PubMed
    Score: 0.195
  36. Reducing glucocorticoid duration in ANCA-associated vasculitis: A pilot trial. Semin Arthritis Rheum. 2018 10; 48(2):288-292.
    View in: PubMed
    Score: 0.192
  37. Emerging Treatment Models in Rheumatology: IgG4-Related Disease: Insights Into Human Immunology and Targeted Therapies. Arthritis Rheumatol. 2017 09; 69(9):1722-1732.
    View in: PubMed
    Score: 0.185
  38. Nationwide Trends in Hospitalizations and In-Hospital Mortality in Granulomatosis With Polyangiitis (Wegener's). Arthritis Care Res (Hoboken). 2017 06; 69(6):915-921.
    View in: PubMed
    Score: 0.182
  39. Large vessel involvement by IgG4-related disease. Medicine (Baltimore). 2016 Jul; 95(28):e3344.
    View in: PubMed
    Score: 0.172
  40. Improved survival in granulomatosis with polyangiitis: A general population-based study. Semin Arthritis Rheum. 2016 Feb; 45(4):483-9.
    View in: PubMed
    Score: 0.161
  41. Response to: 'Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years' by Yamamoto et al. Ann Rheum Dis. 2015 Aug; 74(8):e47.
    View in: PubMed
    Score: 0.158
  42. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015 Jun; 74(6):1171-7.
    View in: PubMed
    Score: 0.156
  43. B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. Ann Rheum Dis. 2015 Dec; 74(12):2236-43.
    View in: PubMed
    Score: 0.151
  44. Efficacy and safety of rituximab for IgG4-related pancreato-biliary disease: A systematic review and meta-analysis. Pancreatology. 2021 Oct; 21(7):1395-1401.
    View in: PubMed
    Score: 0.061
  45. Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis. Genome Med. 2021 02 28; 13(1):35.
    View in: PubMed
    Score: 0.059
  46. Prostate and pancreas involvement are linked in IgG4-related disease. Semin Arthritis Rheum. 2020 12; 50(6):1245-1251.
    View in: PubMed
    Score: 0.057
  47. CD4+ and CD8+ cytotoxic T lymphocytes may induce mesenchymal cell apoptosis in IgG4-related disease. J Allergy Clin Immunol. 2021 01; 147(1):368-382.
    View in: PubMed
    Score: 0.056
  48. Disease Severity Linked to Increase in Autoantibody Diversity in IgG4-Related Disease. Arthritis Rheumatol. 2020 04; 72(4):687-693.
    View in: PubMed
    Score: 0.055
  49. Phospholipase A2 receptor-associated membranous nephropathy in a patient with IgG4-related disease: A case report. Medicine (Baltimore). 2019 May; 98(20):e15616.
    View in: PubMed
    Score: 0.052
  50. Identification of galectin-3 as an autoantigen in patients with IgG4-related disease. J Allergy Clin Immunol. 2019 02; 143(2):736-745.e6.
    View in: PubMed
    Score: 0.049
  51. Lymphomas in IgG4-related disease: clinicopathologic features in a Western population. Virchows Arch. 2018 May; 472(5):839-852.
    View in: PubMed
    Score: 0.048
  52. Atypical IgG4+ Plasmacytic Proliferations and Lymphomas: Characterization of 11 Cases. Am J Clin Pathol. 2017 Sep 01; 148(3):215-235.
    View in: PubMed
    Score: 0.047
  53. Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease. J Allergy Clin Immunol. 2016 09; 138(3):825-838.
    View in: PubMed
    Score: 0.042
  54. International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease. Arthritis Rheumatol. 2015 Jul; 67(7):1688-99.
    View in: PubMed
    Score: 0.040
  55. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol. 2014 Sep; 134(3):679-87.
    View in: PubMed
    Score: 0.037
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.